Attenuated expression of MTR in both prenatally androgenized mice and women with the hyperandrogenic phenotype of PCOS.

OA: gold CC-BY-4.0

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine, metabolic and heterogeneous disorder in women of reproductive age, the exact etiology of which remains unknown. To unravel the molecular mechanisms underlying the hyperandrogenic phenotype of PCOS, prenatally androgenized (PNA) mice were used to mimic this phenotype in women with PCOS. Using microarray analysis, 1188 differentially expressed genes, including 671 upregulated and 517 downregulated genes, were identified in ovaries from PNA mice. Five differentially expressed genes (Aldh1a7, Bhmt, Mtr, Nrcam, Ptprg) were validated, and decreased MTR expression was shown in ovaries of PNA mice. In addition, results from qRT-PCR showed decreased MTR expression in granulosa cells (GCs) from women with the hyperandrogenic phenotype of PCOS. Serum levels of S-adenosyl methionine (SAM), the downstream product of MTR, were also decreased in PNA mice and women with the hyperandrogenic phenotype of PCOS. Our study provides evidence that the hyperandrogenic phenotype of PCOS is linked to abnormal folate one-carbon metabolism.
Full text 30,792 characters · extracted from pmc-nxml · 5 sections · click to expand

Intro

Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic disorders, affecting about 5%-15% of women of reproductive age [ 1 ]. Symptoms of PCOS include amenorrhea or oligomenorrhea, hyperandrogenism, and polycystic ovarian morphology. As a heterogeneous disorder, PCOS shows evidence of a genetic predisposition among patients, but the exact etiology remains unknown [ 2 ]. Previous studies have been conducted on many candidate genes for PCOS, principally related to reproductive hormones, insulin resistance, and chronic inflammation, including follicle-stimulating hormone receptor ( FSHR ) [ 3 ], insulin receptor ( INSR ) [ 4 ], and tumor necrosis factor ( TNF ) [ 5 ]. Microarraywas also used to screen for differentially expressed genes in PCOS using ovaries [ 6 ], theca cells [ 7 ], oocytes [ 8 ], cumulus cells [ 9 ], and even skeletal muscle [ 10 ] and adipose tissue [ 11 ]. The first genome-wide association studies (GWAS) and subsequent follow-ups were performed in Han Chinese women, and investigators identified the following PCOS candidate loci: DENND1A , INSR , YAP1 , C9orf3 , RAB5B , HMGA2 , TOX3 , SUMO1P1/ZNF217 , THADA , FSHR , and LHCGR [ 12 , 13 ]; DENND1A was validated by another study [ 14 ]. Unfortunately, susceptibility genes for PCOS were often controversial in nature in previously reported studies. The controversy is partly due to ethnic differences, but different PCOS phenotypes could also be another reason [ 1 ]. Animal models may help to investigate the pathophysiologic mechanisms in a certain phenotype of PCOS. As an important feature of PCOS, hyperandrogenism is also one of the diagnostic criteria for this disease, a feature distinct from metabolic dysfunction. Therefore, to investigate the etiology of the hyperandrogenic phenotype of PCOS, a prenatally androgenized (PNA) mouse model was validated and used for microarray analysis. Differentially expressed genes (1188) were identified in ovaries from PNA mice, and five of these ( Aldh1a7 , Bhmt , Mtr , Nrcam , Ptprg ) were validated by qRT-PCR; MTR expression was then further evaluated by western immunoblotting analysis and immunohistochemistry. MTR is the only mammalian enzyme that metabolizes N 5 -MeTHF to regenerate the active cofactor tetrahydrofolate (THF)[ 15 ]. The overall reaction converts 5-methyltetrahydrofolate (N 5 -MeTHF) into THF while transferring a methyl group to homocysteine(Hcy) to form methionine(Met). Met is further used to synthesize S-Adenosyl methionine(SAM), the main methyl donor of DNA methylation, under ATP action. Decreased MTR expression in granulosa cells (GCs) from women with the hyperandrogenic phenotype of PCOS was also validated by qRT-PCR. Additionally, serum levels of SAM, the downstream product of MTR, were decreased in both PNA mice and the hyperandrogenic phenotype of women with PCOS. The present study, therefore, provides novel basic information on the relationship between MTR and the hyperandrogenic phenotype of PCOS.

Results

PNA mice exhibited prolonged estrous cycles (8.79 ± 2.58 days, n = 15) compared with controls (4.5 ± 0.46 days, n = 15) ( P < 0.001),which was mainly due to the increased durations of estrus and metestrus. An absence of proestrus was also be observed in the PNA mice ( Fig 1A , S1A and S1B Fig ). Adult PNA mice had fewer litters and smaller litter sizes (1.67 ± 0.52 litters, 4.83 ± 1.25 pups/litter) compared with the controls (3.33 ± 0.52 litters, 14.65 ± 0.91 pups/litter) during a 3- month period ( P < 0.001) ( S1C and S1D Fig ). (A) Representative estrous cycles in control ( Upper ) and PNA mice ( Lower ) (M, metestrus; E, estrus; D, diestrus; P, proestrus). (B) T levels in diestrus mice. (C) (D) HE stained ovarian section of control mouse at 3 months. (E) (F) HE stained ovarian section of PNA mouse at 3 months. (G) Follicle counting at 3 months, numbers represent total counting of every fifth section from serially sectioned ovaries. (H) Proportion of follicles in each stage.(*: P 0.05), but PNA mice had increased T levels at 2 months of age (253.14 ± 90.60 nmol/L, n = 21 vs. 202.79 ± 30.32 nmol/L, n = 15; P = 0.026) and 3 months of age (218.80 ± 41.05 nmol/L, n = 21 vs.170.24 ± 23.21 nmol/L, n = 13; P < 0.001) ( Fig 1B ). These data suggest that PNA treatment elevated T levels in adult PNA mice, but not before puberty. It was also found that T levels at 3 months decreased compared with levels at 3 weeks in the control group, which was not found in the PNA mice. Body weight of PNA mice (13.91 ± 2.84 g, n = 18) was increased compared with the control group (12.01 ± 2.46 g, n = 29) at 3 weeks of age ( P = 0.020), but there was no difference between the two groups after puberty ( S1E Fig ). Ovarian weight of the PNA mice (33.36 ± 8.61 ×10 −4 g, n = 18) was increased compared to the control group (26.45 ± 7.67 ×10 −4 g, n = 29) ( P = 0.006), but the ovarian index was not significantly different between the two groups at 3 weeks of age. At 2 months, the ovarian weight and ovarian index of the PNA mice were both significantly decreased compared to the control group (52.03 ± 21.04 ×10 −4 g, 35.38 ± 10.60%, n = 14 vs.77.67 ± 21.04 ×10 −4 g, 50.54 ± 16.27%, n = 12; P = 0.008, P = 0.009). At 3 months of age, there was no statistical difference in ovarian weight or index between the two groups ( S1F and S1G Fig ). Compared with the controls, ovaries in the adult PNA mice (3 months old) exhibited a greater number of small antral follicles, fewer corpora lutea, but contained cyst-like structures ( Fig 1C–1F ). Although the total number of antral follicles was increased, the number of preovulatory follicles was decreased in the ovaries of adult PNA mice. In addition, antral follicles of the PNA mice exhibited a thinner granulosa cell layer. Follicle counting (n = 10 each group) showed that PNA mice possessed fewer primordial follicles (1126 ± 352.79 vs. 2318.5 ± 491.95, P 0.05) ( Fig 1G ).However, when we analyzed the proportion of follicles at each stage, the PNA mice exhibited a lower percentage of primordial follicles (31.92 ±2.50% vs. 57.95 ± 4.98%, P < 0.001) and a higher percentage of the other three follicular stages (primary, 37.33 ± 2.76% vs. 24.55 ± 4.10%, P < 0.001; secondary, 18.65 ± 3.26% vs. 12.389 ± 1.85%, P < 0.001; antral,12.10 ± 2.70% vs. 5.12 ± 1.11%, P < 0.001) ( Fig 1H ). These results suggested that follicles were overly activated in the PNA mice. RNA extracted from ovaries was qualified using a NanoDrop 2000 and Agilent Bioanalyzer 2100 ( S2 Fig ). Over 39,000 transcripts were analyzed with the GeneChip ® Mouse Genome 430 2.0 Array by using the selection criteria of fold change ≥ 1.5, and a total of 671 gene transcripts were activated while 517 others were repressed in PNA mouse ovaries ( Fig 2A ). Genes involved in androgen biosynthesis and LH secretion ( Hsd11b1 , Hsd17b2 , Hsd17b7 , Cyp11a1 , Cyp17a1 , Cyp19a1 , Cyp2d22 , Cyp39a1 , Cyp4f18 and Lhcgr ), ovarian function and folliculogenesis ( Pten , Amh and Nppc ), and inflammation ( CCL2 , CCL5 , CCL7 , CXCL1 , CXCL9 , CXCL10 , and CCR7 ) were among those with differential expression. (A) Heatmap of microarray analysis. (B) -(F) Five differentially expressed genes were validated by qRT-PCR(B, Mtr ; C, Aldh1a7 ; D, Bhmt ; E, Nrcam ; F, Ptprg ).(*: P < 0.05). The differentially expressed genes were enriched and analyzed according to the gene information of all pathways in KEGG and BIOCARTA. The top 3 pathways were cancer, cytokine-cytokine receptor interaction, and chemokine signaling pathway; the top 3 under biological processes were signal transduction, multicellular organismal development and anatomical structure development; and the top 3 molecular functions were receptor binding, receptor activity and enzyme regulator activity ( S2 – S4 Tables). To validate the expression changes identified by microarray analysis, the expression levels of 5 differentially expressed genes ( Aldh1a7 , Bhmt , Mtr , Nrcam , Ptprg ) were assessed by qRT-PCR ( Fig 2B–2F ). Results showed that the 5 selected genes displayed a trend similar to that of the microarray data, thus confirming the validity of the microarray results. By IHC, we found that MTR was mainly expressed in granulosa cells, and rarely expressed in theca cells ( Fig 3C and 3D ).Subcellular localization of MTR showed the greatest expression in the cytoplast and was not appreciably observed in the nucleus ( Fig 3B–3D ). The expression of MTR in the ovaries of adult PNA mice (at 3 months of age) was significantly decreased compared with the controls ( P = 0.014; Fig 3E ). (A)–(D) Immunohistochemistry. (A) Negative control (ovary). (B) Positive control (pancreas). (C) Ovary of control mouse. (D) Ovary of PNA mouse. (E) IOD of MTR was significantly lower in PNA mice. (*: P < 0.05). (F) WB showed expression of MTR in ovaries of PNA mice decreased at 3 months age. (G) WB showed expression of MTR in ovaries of PNA mice decreased at 3 weeks age. Western-blot analysis also confirmed the above results. The expression of MTR in the ovaries of PNA mice was decreased at both 3 weeks and 3 months of age ( Fig 3F and 3G ). Although we also observed for adult mice in the control group an attenuated expression of MTR compared with mice before puberty, this change was not obvious in PNA mice ( S3 Fig ). These results indicated that the expression of MTR was decreased in the ovaries of PNA mice even prior to puberty. SAM is the downstream product of MTR, and ELISA showed that serum SAM levels were significantly decreased in PNA mice (21.41 ± 9.79 ng/ml) compared with the control group (15.20 ± 5.62 ng/ml)(n = 21 in each group, P = 0.016; Fig 4A ). (A) PNA decreases serum SAM levels in mouse. (B) Women with PCOS have low- expressed MTR in GCs. (C) low- SAM level in serum of women with PCOS.(*: P < 0.05). Characteristics of patients are shown in Table 1 . The control groups and patients showing the hyperandrogenic phenotype of PCOS were matched for age. Serum E 2 and PRL were not significantly different between the two groups. However, BMI, Mean arterial pressure (MAP), ovarian volume, serum LH, T and the LH/FSH ratio of the patients with PCOS were higher than the controls (BMI, 23.38 ± 3.87 kg/m 2 vs. 21.71 ± 3.07 kg/m 2 ; MAP, 90.90 ± 11.33mmHg vs. 85.41± 9.01mmHg; ovarian volume, 8.33 ± 3.79 cm 3 vs. 4.82 ± 2.04cm 3 ; LH,10.19 IU/L ± 7.66 vs. 4.28 ± 1.61 IU/L; T, 0.67 ± 0.29 vs. 0.42 ± 0.14; LH/FSH, 1.70 ± 1.18 vs. 0.63 ± 0.23; P < 0.05). Additionally, more oocytes were retrieved from PCOS patients (15.19 ± 5.00) compared to controls (12.18 ± 4.19) ( P < 0.001). These results showed that many physiologic differences were typically observed between PCOS patients and controls. The expression of MTR in GCs from women with the hyperandrogenic phenotype of PCOS was significantly decreased compared with controls ( P = 0.036; Fig 4B ). Furthermore, serum SAM levels were significantly lower in PCOS patients (50.01 ± 19.21 ng/ml) compared to controls (68.26 ± 29.29 ng/ml) (n = 42 in each group, P = 0.001; Fig 4C ).

Conclusions

Prenatal androgenization of the ICR mouse with DHT can replicate most of the common clinical features of PCOS, especially the hyperandrogenic phenotype of PCOS. By using this mouse model we demonstrate that PCOS is characterized by decreased MTR expression and serum SAM, which can potentially explain the dysregulated DNA methylation patterns in PCOS patients. Our evidence for the first time shows that an abnormal one-carbon metabolism pathway is linked to the hyperandrogenic phenotype of PCOS, the causality of which will be examined in our ongoing research.

Materials|Methods

All experimental procedures were performed in accordance with the guidelines of the Experimental Animals Management Committee (Jiangsu Province, China) and were approved by Nanjing Drum Tower Hospital Experimental Animals Welfare &Ethical committee (20150302).Adult ICR mice (females, 6 weeks of age, n = 50; males, 10 weeks of age, n = 10) were purchased from the Animal Experimental Center of Yangzhou University (Jiangsu Province, China), and housed in the Drum Tower Hospital Animal Experimental Center (Jiangsu Province, China) at 22°C, on a 12 h light/12 h dark cycle with lights on at 07:00 am, and with ad libitum access to chow and water. Females were mated with males and checked for copulatory plugs daily. The date of the plug was considered day 1 of gestation. Pregnant dams were injected daily s.c. with 70 μl of sesame oil containing 350 μg of DHT (521-18-6, Sigma, USA)or sesame oil vehicle on days 16–18 of gestation, and female offspring were studied. The mice were euthanized through anesthesia with chloral hydrate. Tissues and blood were harvested from all animals post euthanization. The body weights of PNA and control mice were recorded, starting at 21 days of age. Vaginal smears were obtained daily in all adult mice from 2 months of age for 3 weeks or those showing consecutive estrous cycles. The fertility of adult mice (n = 6 each group) was tested by mating with proven fertile ICR males (1: 1) for 3 months. The numbers of litters and pups per litter were recorded. The mice were anesthetized with chloral hydrateon diestrus, and blood was collected from the posterior orbital venous plexus. The blood samples were then centrifuged and the serum was frozen at -80°C for hormonal analysis. The concentration of testosterone (T) was measured using an ELISA kit (YANYU, Shanghai, China), and the serum levels of SAM were also detected using an ELISA kit (CEG414Ge, Cloud-Clone Corp, Wuhan, China). After blood was collected from mice, ovaries were removed, weighted and then fixed in Bouin’s solution. Ovarian index was calculated using ovarian weight * 1000/body weight * 100 (%). After fixation for 4–6 h, the samples were dehydrated and embedded in paraffin, sections cut at 5 μm, and every fifth section was stained with hematoxylin and eosin (H&E). Follicle counting was performed using an unbiased stereologic method. Only follicles containing an oocyte nucleus were counted. The total number of follicles was then multiplied by five. Follicles were classified according to the classification system in a previous report [ 16 ]. The microarray was conducted by Genechem Co., Ltd. (Shanghai, China). The GeneChip ® Mouse Genome 430 2.0 Array (900496, Affymetrix) was used for the experiment, and 2 groups of samples were tested, with each group containing 5 mouse ovaries. RNA was extracted using Trizol reagents, and qualified with a NanoDrop 2000 and Agilent Bioanalyzer 2100. The quality control standards were as follows:1.7 < A260/A280 0.7 (Agilent 2100 Bioanalyzer). The qualifying samples were entered into the microarray experiment. RNA was extracted using Trizol reagents and measured with spectrometry for OD260/280. cDNA was prepared with 5× All-In-One RT MasterMix (G490, ABM, USA) according to the manufacturer’s recommendations. Real-time PCR was performed with a SYBR-Green Mixture (Bio-Rad, USA). Primers were searched from https://pga.mgh.harvard.edu/primerbank/ . The sequences of specific PCR primers in this study are listed in S1 Table . Primers were synthesized by Sangon (Sangon Biotech, Shanghai, China).Each sample was run in triplicate as follows: 2 μl cDNA, 1 μl primer, 7 μldd H 2 O, and 10 μl SYBR Green Master Mix in a total volume of 20 μl; and 18s rRNA was measured as an internal control. The PCR procedure was as follows: initial denaturation at 95°Cfor 1 min followed by 40 cycles of amplification (denaturation at 95°C for 15 sec, annealing at 60°C for 1 min), and then primer template extension at 72°C for 3 min. Melting curve analysis was performed to confirm the specificity of amplification, and the relative MTR level was determined using 2 −ΔΔCT . The expression of MTR was also confirmed by immunohistochemistry. Sections were baked at 65°C, dehydrated, and incubated in 3% H 2 O 2 . Sections were subjected to antigen retrieval by boiling in 10 mM citrate buffer (pH 6.0), and rinsed in TBS. We added solution A (Biotin block), washed with TBS, added solution B (Biotin block), and we again washed sections with TBS. Sections were incubated in normal goat serum for 1 h at 4°C, incubated with anti-MTR (1:200, ab66039, Abcam, UK) in 3% BSA overnight at 4°C, incubated in biotinylated goat anti-rabbit IgG (1:200 dilution) for 2 h at room temperature, and then washed with PBS. We added reagent SABC (12E02A, BOSTER, Wuhan, China) and incubated sections at 37°C for 20 min, washed with PBST, visualized binding with DAB, and terminated the incubation with distilled water. Slides were stained with hematoxylin, dehydrated, and mounted. The average integrated optical density (IOD) was measured for each sample by Image-pro Plus 6.0 (Media Cybernetics, USA). Ovarian lysates from mice were separated by SDS/PAGE and transferred onto nitrocellulose membranes. Membranes were probed with polyclonal MTR antibodies (1:2000, ab66039, Abcam, UK), and blots were visualized by using peroxidase-conjugated second antibody and an ECL detection kit (Amersham Pharmacia Biosciences). Western blot data were quantified and normalized to GAPDH (1:10000, Bio-Rad, USA). Women with the hyperandrogenic phenotype of PCOS and age-matched controls were recruited from the Center for Reproductive Medicine, Nanjing Drum Tower Hospital, from January to December 2016. All subjects were unrelated Han Chines eand were recruited after providing informed written consent. The study was approved by the Medical Ethical Committee of Nanjing Drum Tower Hospital. The diagnosis of PCOS was based upon the 2003 Rotterdam Diagnostic Criteria [ 17 ].All patients with PCOS in this study had oligomenorrhea, hyperandrogenism, and a clear diagnosis of polycystic ovaries by ultrasonography. The controls were fertile women undergoing IUI or IVF for male factor infertility; women with ovarian factor or complications affecting ovulation (e.g., hypothyroidism, diabetes mellitus, endometriosis, hyperprolactinemia) were excluded. On cycle days 2 or 3, venous blood samples were collected; and serum hormone levels, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), estradiol (E 2 ) and testosterone (T), were measured using ELISA Kits (FSH, 33520; LH, 33510; PRL, 33530; E 2 , 33540; T, 33560; Beckman Coulter, Inc, USA). Blood samples were also collected and centrifuged on the day before HCG was injected, and serum was frozen at -80°C for SAM analysis (CEG414Ge, Cloud-Clone Corp, Wuhan, China). Ultrasonography was performed on cycle day 4 or 5 to measure the thickness of endometrium, count the number of antral follicles and confirm the absence of corpus luteum. All women were injected with gonadotropin-releasing hormone (GnRH) agonist at the beginning of the midluteal phase, and then ultrasonographic scans and serum estradiol assays were performed to monitor follicular size. When 3 or more follicles with a mean diameter of 16 mm were observed, 5000–10,000 IU human chorionic gonadotropin (HCG) was injected. Ultrasound-guided oocyte retrieval was performed 36 hours later. The granulosa cells (GCs) around oocytes were collected and washed twice with Dulbecco’s modified Eagle’s medium (DMEM) after removal of the oocyte, and kept in TRIzol (15596–018, Invitrogen, USA) at -80°C for RNA isolation. Statistical analysis was performed using SPSS 19.0 (IBM, USA). The means ± SD of the data were calculated. Either Student’s t -test or t’ -test was used to determine the significance between the two groups. A P value < 0.05 was considered to be statistically significant.

Supplementary Material

(DOCX) Click here for additional data file. (DOCX) Click here for additional data file. (DOCX) Click here for additional data file. (DOCX) Click here for additional data file. (A) PNA mice exhibited prolonged estrous cycles. (B) Percent of days spent in each estrous cycle stage.(C) (D) PNA mice produced fewer litters and smaller litter sizes. (F) T levels in adult diestrus mice.(E) Body weight of mice. (F) Ovarian weight of mice. (G) Ovarian index of mice.(*: P < 0.05). (TIF) Click here for additional data file. (A) Results summary table. (B) (C) Result of Agilent 2100 Bioanalyzer. (TIF) Click here for additional data file. (A) Expression of MTR in ovaries decreased in 3 months control mice. (B) Expression of MTR in ovaries did not change in PNA mice. (TIF) Click here for additional data file.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-04T06:16:37.499272+00:00
unpaywall
last seen: 2026-05-21T02:00:01.467718+00:00
License: CC-BY-4.0